Results 51 to 60 of about 2,383 (91)
Antiviral activities of sotrovimab against BQ.1.1 and XBB.1.5 in sera of treated patients
, 2023 Bruel T, Vrignaud L, Porrot F, Staropoli I, Planas D, Guivel-Benhassine F, Puech J, Prot M, Munier S, Henry-Bolland W, Soulié C, Zafilaza K, Lusivika-Nzinga C, Meledge M, Dorival C, Molino D, Péré H, Yordanov Y, Simon-Lorière E, Veyer D, Carrat F, Schwartz O, Marcelin A, Martin-Blondel G, the ANRS 0003S CoCoPrev Study Group. +24 moreeuropepmc +1 more sourceClinical Phenotypes of Critically Ill Patients with COVID-19 Infected with Omicron: A Nationwide Prospective Cohort Study. [PDF]
Infect Dis TherAudureau E, Bay P, Préau S, Favory R, Guigon A, Heming N, Gault E, Pham T, Chaghouri A, Turpin M, Morand-Joubert L, Jochmans S, Pitsch A, Meireles S, Contou D, Henry A, Roux D, Le Hingrat Q, Kimmoun A, Hartard C, Pène F, L'Honneur AS, Guillon A, Handala L, Tamion F, Moisan A, Daix T, Hantz S, Delamaire F, Thibault V, Darreau C, Thomin J, Pawlotsky JM, Fourati S, de Prost N, SEVARVIR investigators. +35 moreeuropepmc +1 more sourceCorrection: COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants. [PDF]
Ann Intensive CareBay P, Audureau E, Préau S, Favory R, Guigon A, Heming N, Gault E, Pham T, Chaghouri A, Turpin M, Morand-Joubert L, Jochmans S, Pitsch A, Meireles S, Contou D, Henry A, Joseph A, Chaix ML, Uhel F, Roux D, Descamps D, Emery M, Garcia-Sanchez C, Levy D, Burrel S, Mayaux J, Kimmoun A, Hartard C, Pène F, Rozenberg F, Gaudry S, Brichler S, Guillon A, Handala L, Tamion F, Moisan A, Daix T, Hantz S, Delamaire F, Thibault V, Souweine B, Henquell C, Picard L, Botterel F, Rodriguez C, Dessap AM, Pawlotsky JM, Fourati S, de Prost N, SEVARVIR investigators. +49 moreeuropepmc +1 more sourceViral clearance and escape during therapy of COVID-19 outpatients: A prospective cohort study. [PDF]
iScienceMartin-Blondel G, Burgat P, Leducq V, Porrot F, Cottignies-Calamarte A, De Cruz A, Dorival C, Romieu-Mourez R, Chaubet C, Cazaentre V, Boumaza X, Richier Q, Gaborit B, Coustilleres F, Dubée V, Ader F, Yordanov Y, Schwartz O, Marcelin AG, Lusivika-Nzinga C, Carrat F, Soulié C, Liblau R, Bruel T, ANRS 0003S CoCoPrev Study Group. +24 moreeuropepmc +1 more sourceCOVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants. [PDF]
Ann Intensive CareBay P, Audureau E, Préau S, Favory R, Guigon A, Heming N, Gault E, Pham T, Chaghouri A, Turpin M, Morand-Joubert L, Jochmans S, Pitsch A, Meireles S, Contou D, Henry A, Joseph A, Chaix ML, Uhel F, Roux D, Descamps D, Emery M, Garcia-Sanchez C, Levy D, Burrel S, Mayaux J, Kimmoun A, Hartard C, Pène F, Rozenberg F, Gaudry S, Brichler S, Guillon A, Handala L, Tamion F, Moisan A, Daix T, Hantz S, Delamaire F, Thibault V, Souweine B, Henquell C, Picard L, Botterel F, Rodriguez C, Mekontso Dessap A, Pawlotsky JM, Fourati S, de Prost N, SEVARVIR investigators. +49 moreeuropepmc +1 more source